Routine care for diabetes and chronic conditions has been significantly disrupted by the pandemic with nearly 53% of people having simply abandoned care they would have otherwise received.

Learn how Omada for Diabetes is providing personalized care for those in your workforce and demonstrating proven clinical outcomes, including:

• Reduced average Hemoglobin A1C by 0.8 percent for all study participants
• Average decrease of 39 points in total cholesterol for those with high cholesterol
• Increased medication adherence by additional 11%
• Meaningful decreases in diabetes distress